Delo Wonders about the Macroeconomic Effects of Lek Takeover
Ljubljana, 30 August - While Switzerland's Novartis is about to enter Lek, it is not certain yet that the takeover will actually be carried out. This will not only depend on the shareholders. Novartis has protected itself against exchange fluctuations, so that the takeover bid will not be published if the Swiss notice considerable changes in the tolar-euro ratio. The issue here is an overpriced tolar, of course, Delo writes on Friday.
The rest of this news item is available to subscribers.
The news item consists of 857 characters (without spaces) or 176 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.